Your browser doesn't support javascript.
loading
A Single-Arm Phase II Trial of Lenalidomide in Relapsing or Refractory Primary Cutaneous Large B-Cell Lymphoma, Leg Type.
Beylot-Barry, Marie; Mermin, Diane; Maillard, Aline; Bouabdallah, Reda; Bonnet, Nathalie; Duval-Modeste, Anne-Bénédicte; Mortier, Laurent; Ingen-Housz-Oro, Saskia; Ram-Wolff, Caroline; Barete, Stéphane; Dalle, Stéphane; Maubec, Eve; Quereux, Gaelle; Templier, Isabelle; Bagot, Martine; Grange, Florent; Joly, Pascal; Vergier, Béatrice; Vially, Pierre-Julien; Gros, Audrey; Pham-Ledard, Anne; Frison, Eric; Merlio, Jean-Philippe.
Affiliation
  • Beylot-Barry M; Dermatology Department, CHU Bordeaux, Bordeaux, France; INSERM U1053, Bordeaux Research in Translational Oncology, Team 3 oncogenesis of cutaneous lymphomas, Université de Bordeaux, Bordeaux, France. Electronic address: marie.beylot-barry@chu-bordeaux.fr.
  • Mermin D; Dermatology Department, CHU Bordeaux, Bordeaux, France.
  • Maillard A; Service d'information médicale CHU Bordeaux, Bordeaux, France.
  • Bouabdallah R; Cancer Institute Paoli Calmette, Marseille, France.
  • Bonnet N; Dermatology Department, CHU Marseille, Marseille, France.
  • Duval-Modeste AB; Dermatology Department, Rouen University Hospital and INSERM U905, Normandie University, Rouen, France.
  • Mortier L; Dermatology Department, CHU Lille, Lille University, INSERM U1189, Lille, France.
  • Ingen-Housz-Oro S; Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France.
  • Ram-Wolff C; Dermatology Department, Hospital Saint-Louis, Paris 7 University, Paris, France.
  • Barete S; Dermatology Department, University Hospital Tenon, Paris, France.
  • Dalle S; Dermatology Department, Centre de Recherche en Cancérologie de Lyon, Hospices Civils de Lyon, Lyon University, Lyon, France.
  • Maubec E; Dermatology Department, University Hospital Bichat, Paris, France.
  • Quereux G; Dermatology Department, CHU Nantes, Nantes, France.
  • Templier I; Dermatology Department, CHU Grenoble, Grenoble, France.
  • Bagot M; Dermatology Department, Hospital Saint-Louis, Paris 7 University, Paris, France.
  • Grange F; Dermatology Department, CHU Reims, Reims, France.
  • Joly P; Dermatology Department, Rouen University Hospital and INSERM U905, Normandie University, Rouen, France.
  • Vergier B; INSERM U1053, Bordeaux Research in Translational Oncology, Team 3 oncogenesis of cutaneous lymphomas, Université de Bordeaux, Bordeaux, France; Pathology Department, CHU Bordeaux, Hospital Haut-Lévêque, Pessac, France.
  • Vially PJ; INSERM U1245, Team Genomics and Biomarkers in Lymphoma and Solid Tumors, UNIROUEN, Université de Normandie, Rouen, France.
  • Gros A; INSERM U1053, Bordeaux Research in Translational Oncology, Team 3 oncogenesis of cutaneous lymphomas, Université de Bordeaux, Bordeaux, France; Tumor Bank and Tumor Biology Laboratory, CHU Bordeaux, Pessac, France.
  • Pham-Ledard A; Dermatology Department, CHU Bordeaux, Bordeaux, France; INSERM U1053, Bordeaux Research in Translational Oncology, Team 3 oncogenesis of cutaneous lymphomas, Université de Bordeaux, Bordeaux, France.
  • Frison E; Service d'information médicale CHU Bordeaux, Bordeaux, France.
  • Merlio JP; INSERM U1053, Bordeaux Research in Translational Oncology, Team 3 oncogenesis of cutaneous lymphomas, Université de Bordeaux, Bordeaux, France; Tumor Bank and Tumor Biology Laboratory, CHU Bordeaux, Pessac, France.
J Invest Dermatol ; 138(9): 1982-1989, 2018 09.
Article in En | MEDLINE | ID: mdl-29596904
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Lymphoma, Large B-Cell, Diffuse / Lenalidomide Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: J Invest Dermatol Year: 2018 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Lymphoma, Large B-Cell, Diffuse / Lenalidomide Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: J Invest Dermatol Year: 2018 Document type: Article Country of publication: